Skip to main content

Advertisement

SpringerLink
Log in

Lupoid sclerosis

  • Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Lupoid sclerosis (LS) is a controversial entity, comprising features of both systemic lupus erythematosus and multiple sclerosis. Diagnostic criteria are a matter of debate, as well as the role of antinuclear and antiphospholipid antibodies. In this review, clinical and laboratory findings of LS available on Pubmed up to date are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Feletar M, Ibanez D, Urowitz MG, Gladman DD (2003) The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed? Arthritis Rheum 48(7):2067–2069

    Article  CAS  PubMed  Google Scholar 

  2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306

    Article  CAS  PubMed  Google Scholar 

  3. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “MacDonald Criteria”. Ann Neurol 58:840–846

    Article  PubMed  Google Scholar 

  4. Levine SR, Welch KM (1987) The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulant and anticardiolipin antibodies. Arch Neurol 44:876–883

    CAS  PubMed  Google Scholar 

  5. Theodoridou A, Settas L (2006) Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry 77(3):290–295

    CAS  PubMed  Google Scholar 

  6. Shepherd DI, Downie AW, Best PV (1974) Systemic lupus erythematosis and multiple sclerosis. Trans Am Neurol Assoc 99:173–176

    CAS  PubMed  Google Scholar 

  7. Stepien M, Cendrowski W (1974) Form of systemic lupus erythematosus (lupoid sclerosis) resembling multiple sclerosis. Neurol Neurochir Pol 8:607–609

    CAS  PubMed  Google Scholar 

  8. Kaplan PE, Betts HB (1977) Lupoid sclerosis: evaluation and treatment. Arch Phys Med Rehabil 58:24–28

    CAS  PubMed  Google Scholar 

  9. Ellenberg M (1978) Lupoid sclerosis. Arch Phys Med Rehabil 59:43–44

    CAS  PubMed  Google Scholar 

  10. Knapik-Kordecka M, Plamieniak Z (1980) Case of visceral lupus erythematosus coexisting with multiple sclerosis. Pol Tyg Lek 35(28):1075–1076

    CAS  PubMed  Google Scholar 

  11. Rosati G, Serra G, Trotta F, Tralli G, Artioli M (1981) Systemic lupus erythematosus and multiple sclerosis. Riv Neurobiol 27(1):158–164

    CAS  PubMed  Google Scholar 

  12. Hutchinson M, Bresnihan B (1983) Neurological lupus erythematosus with tonic seizures simulating multiple sclerosis. J Neurol Neurosurg Psychiatry 46(6):583–585

    Article  CAS  PubMed  Google Scholar 

  13. Hoppe B, Zajaczek-Grabowska A (1984) Diagnostic difficulties in a case of visceral lupus with disseminated neurological signs. Neurol Neurochir Pol 18:489–491

    CAS  PubMed  Google Scholar 

  14. Harris EN, Gharavi AE, Mackworth-Young CG, Patel BM, Derue G, Hughes GRV (1985) Lupoid sclerosis: a possible role for antiphospholipid antibodies. Ann Rheum Dis 44:281–283

    Article  CAS  PubMed  Google Scholar 

  15. Lorcerie B, Marchal G, Borsotti JP, Guard O, Giroud M, Dumas R et al (1989) Multiple sclerosis associated with biological symptoms of systemic lupus erythematosus. A case with anatomical study. Rev Med Interne 10:471–474

    Article  CAS  PubMed  Google Scholar 

  16. Moriwaka F, Tashiro K, Fukazawa T, Akino M, Yasuda I, Sagawa A, Hida K (1990) A case of systemic lupus erythematosus: its clinical and MRI resemblance to multiple sclerosis. Jpn J Psychiatry Neurol 44(3):601–605

    CAS  PubMed  Google Scholar 

  17. van der Kaaden AJ, Kamphuis DJ, Nossent JC, Rico RE (1993) Longstanding isolated cerebral systemic lupus erythematosus in an 8-year-old black girl. Resemblance with multiple sclerosis. Clin Neurol Neurosurg 95(3):241–244

    Article  PubMed  Google Scholar 

  18. Kinnunen E, Müllher K, Keto P, Ketonen L, Helve T, Sepponen R (1993) Cerebrospinal fluid and MRI findings in three patients with multiple sclerosis and systemic lupus erythematosus. Acta Neurol Scand 87:356–360

    Article  CAS  PubMed  Google Scholar 

  19. Dabadghao S, Aggarwal A, Misra R (1995) Lupoid sclerosis with raised anticardiolipin antibodies. J Assoc Physicians India 43:298

    CAS  PubMed  Google Scholar 

  20. Banerjee S, Kumar L, Singh S, Kakkar N (1997) Multiple sclerosis and systemic lupus erythematosus in a 10-year-old girl. Indian Pediatr 34(2):159–162

    CAS  PubMed  Google Scholar 

  21. Schantz V, Oestergaard LL, Junker P (1998) Shrinking spinal cord following transverse myelopathy in a patient with systemic lupus erythematosus and the phospholipid antibody syndrome. J Rheumatol 25(7):1425–1428

    CAS  PubMed  Google Scholar 

  22. Carter D, Olchovski D, Yonath H, Langevitz P, Ezra D (2006) Simultaneous deep vein thrombosis and transverse myelitis with negative sorology as a first sign of antiphospholipid syndrome: a case report and review of the literature. Clin Rheumatol 25:756–758

    Article  PubMed  Google Scholar 

  23. Lima I, Melo A, Brandi IV, Costa O, Santiago M (2007) Lupoid sclerosis: what is the role of antiphospholipid antibodies? J Clin Rheumatol 13:85–86

    Article  PubMed  Google Scholar 

  24. Kasitanon N, Louthrenoo W, Piyasirisilp S, Sukitawu W, Wichainun R (2002) Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 20(3):179–185

    PubMed  Google Scholar 

  25. Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ (2000) Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59(2):120–124

    Article  CAS  PubMed  Google Scholar 

  26. Mok CC, Lau CS, Chan EY, Wong RW (1998) Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. J Rheumatol 25(3):467–473

    CAS  PubMed  Google Scholar 

  27. Inslicht DV, Stein AB, Pomerantz F, Ragnarsson KT (1998) Three women with lupus transverse myelitis: case reports and differential diagnosis. Arch Phys Med Rehabil 79(4):456–459

    Article  CAS  PubMed  Google Scholar 

  28. Zenone T, Steineur MP, Sibille M, Durieu I, Vital Durand D (2000) Myelopathy revealing lupus. Two cases and review of the literature. Rev Med Interne 21:1114–1120

    Article  CAS  PubMed  Google Scholar 

  29. D’Cruz DP, Mellor-Pita S, Joven B, Sanna G, Allanson J, Taylor J et al (2004) Transverse myelitis as the first manifestation of systemic lupus erythematosus and lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. Rheumatology 31:280–285

    Google Scholar 

  30. Téllez-Zenteno JF, Remes-Troche JM, Negrete-Pulido RO, Dávila Maldonado L (2001) Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases. Lupus 10:851–856

    Article  PubMed  Google Scholar 

  31. Lehnhard FR, Impekoven P, Rubbert A, Burghaus L, Nevelin M, Heiss WD, Jacobs AH (2004) Recurrrent longitudinal myelitis as primary manifestation of SLE. Neurology 63(10):1976

    Google Scholar 

  32. Heinlein AC, Gertner E (2007) Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus. Lupus 16(10):823–826

    Article  CAS  PubMed  Google Scholar 

  33. Kim JH, Lee SI, Park SI, Yoo WH (2004) Recurrent transverse myelitis in primary antiphospholipid syndrome—case report and literature review. Rheumatol Int 24:244–246

    CAS  PubMed  Google Scholar 

  34. Takamura Y, Morimoto S, Tanooka A, Yoshikawa J (1996) Transverse myelitis in a patient with primary antiphospholipid syndrome. A case report. No To Shinkei 48:851–855

    CAS  PubMed  Google Scholar 

  35. Shaharao V, Bartakke S, Muranjan MN, Bavdekar MS, Bavdekar SB, Udani VP (2004) Recurrent acute transverse myelopathy: association with antiphospholipid antibody syndrome. Indian J Pediatr 71:559–561

    Article  PubMed  Google Scholar 

  36. Chapman J (2004) The interface of multiple sclerosis and antiphospholipid antibodies. Thromb Res 114:477–481

    Article  CAS  PubMed  Google Scholar 

  37. Ferreira S, D’Cruz DP, Hughes GR (2005) Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) 44:434–442

    Article  CAS  Google Scholar 

  38. Suárez Alvarez L, Hughes GR, Khamashta MA (2005) Neurological manifestations of the antiphospholipid syndrome. Med Clin (Barc) 124:630–633

    Article  Google Scholar 

  39. Ijdo JW, Conti-Kelly AM, Greco P, Abedi M, Amos Provenzale JM et al (1999) Antiphospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus 8:109–115

    Article  CAS  PubMed  Google Scholar 

  40. Cuadrado MJ, Khamastha MA, Ballesterol A, Godfrey T, Simon MF, Hughes GR (2000) Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 79:57–68

    Article  CAS  Google Scholar 

  41. Marullo S, Clauvel JP, Intrator L, Danon F, Brouet JC, Oksenhendler E (1993) Lupoid sclerosis with antiphospholipid and antimyelin antibodies. J Rheumatol 20:747–749

    CAS  PubMed  Google Scholar 

  42. Inoue Y, Yoshino H (1998) Acute transverse myelitis presenting with syrinx formation associated with anti-sulfated glucuronyl lactosaminyl paragloboside antibody and anticardiolipin antibodies. No To Shinkei 50:181–185

    CAS  PubMed  Google Scholar 

  43. Wingerchuck DM, Hogancamp WF, O’Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 53:1107–1114

    Google Scholar 

  44. Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E et al (2004) Italian Devic’s Study Group (IDESG). Clinical characteristics, course and prognosis of relapsing Devic’s Neuromyelitis Optica. J Neurol 251:47–52

    Article  PubMed  Google Scholar 

  45. Scott TF, Kassab SL, Pittock SJ (2006) Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol 63:1398–1400

    Article  PubMed  Google Scholar 

  46. Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B (2008) Vanderbilt. Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4(4):202–214

    CAS  PubMed  Google Scholar 

  47. April RS, Vansonnenberg E (1976) A case of neuromyelitis optica (Devic’s syndrome) in systemic lupus erythematosus. Clinicopathologic report an review of the literature. Neurology 26:1066–1070

    CAS  PubMed  Google Scholar 

  48. Jacobi C, Stingele K, Kretz R, Hartmann M, Storch-Hagenlocher B, Breitbart A et al (2006) Neuromyelitis optica (Devic’s syndrome) as first manifestation of systemic lupus erythematosus. Lupus 15:107–109

    Article  CAS  PubMed  Google Scholar 

  49. Ferreira S, Marques P, Carneiro E, D’Cruz D, Gama G (2005) Devic’s syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome. Rheumatology (Oxford) 44:693–695

    Article  CAS  Google Scholar 

  50. de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier-Vehier F et al (2002) Devic’s neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 197:57–61

    Article  PubMed  Google Scholar 

  51. Govoni M, Padovan M, Rizzo N, Trotta F (2001) CNS involvement in primary Sjogren’s syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach. CNS Drugs 15:597–607

    Article  CAS  PubMed  Google Scholar 

  52. Mellgren SI, Göransson LG, Omdal R (2007) Primary Sjögren’s syndrome associated neuropathy. 1. Can J Neurol Sci 34(3):280–287

    PubMed  Google Scholar 

  53. Yamamoto T, Ito S, Hattori T (2006) Neurological picture. Acute longitudinal myelitis as the initial manifestation of Sjögren’s syndrome. J Neurol Neurosurg Psychiatry 77(6):780

    Article  CAS  PubMed  Google Scholar 

  54. Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG (1995) Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 98(1):32–41

    Article  CAS  PubMed  Google Scholar 

  55. Fukui W, Sano H, Tanabe T, Ueda T, Hirohata S, Hashiramoto A, Yamada R, Kato H, Kondo M (1998) A case of severe neuropsychiatric lupus erythematosus treated by plasmapheresis: diagnostic values of serum antiribosomal P protein antibodies and interleukin-6 in cerebrospinal fluid. Nihon Rinsho Meneki Gakkai Kaishi 21(4):172–179

    CAS  PubMed  Google Scholar 

  56. Taniguchi Y, Yorioka N, Okushin S, Oda H, Usui K, Yamakido M (1995) Usefulness of immunoadsorption therapy for systemic lupus erythematosus associated with transverse myelitis. A case report. Int J Artif Organs 18(12):799–801

    CAS  PubMed  Google Scholar 

  57. Armstrong DJ, McCarron MT, Wright GD (2006) SLE-associated transverse myelitis successfully treated with Rituximab (anti-CD20 monoclonal antibody). Rheumatol Int 26(8):771–772

    Article  CAS  PubMed  Google Scholar 

  58. Lehnhardt FG, Scheid C, Holtik U, Burghaus L, Neveling M, Impekoven P, Rüger A, Hallek M, Jacobs AH, Rubbert A (2006) Autologous blood stem cell transplantation in refractory systemic lupus erythematodes with recurrent longitudinal myelitis and cerebral infarction. Lupus 15(4):240–243

    Article  CAS  PubMed  Google Scholar 

  59. Yamawaki T, Suzuki N (1997) Can immunoadsorption plasmapheresis be used as the first choice therapy for neuroimmunological disorders? Ther Apher 1(4):348–352

    Article  CAS  PubMed  Google Scholar 

  60. Keiserman B, Garcias da Silva LF, Keiserman MW, von Mühlen CA, Staub HL (2008) Polemics on lupoid sclerosis. Rev Bras Rheumatol 48(1):62–65

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Sao Lucas Hospital, Pontifical Catholic University of Rio Grande do Sul, Av. Ipiranga 6690/220, 90610-000, Porto Alegre, Brazil

    Briele Keiserman, Mauro W. Keiserman, Carlos Alberto von Mühlen & Henrique Luiz Staub

  2. Department of Neurology, Faculty of Medicine, Sao Lucas Hospital, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil

    Luiz Fernando Garcias da Silva

Authors
  1. Briele Keiserman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luiz Fernando Garcias da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mauro W. Keiserman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlos Alberto von Mühlen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Henrique Luiz Staub
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Briele Keiserman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keiserman, B., da Silva, L.F.G., Keiserman, M.W. et al. Lupoid sclerosis. Rheumatol Int 30, 431–434 (2010). https://doi.org/10.1007/s00296-009-1175-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-1175-1

Keywords

Search

Navigation